What is Bevacizumab-maly: Uses, Dosage, Side Effects and More

Bevacizumab-maly is a targeted cancer treatment that works by blocking the growth of new blood vessels that tumors need to survive and spread. This medication belongs to a class of drugs called monoclonal antibodies, which are specially designed proteins that target specific parts of cancer cells. Your doctor may recommend this treatment as part of your cancer care plan, often combined with other therapies to give you the best possible outcome.

What is Bevacizumab-maly?

Bevacizumab-maly is a biosimilar version of the original bevacizumab medication, meaning it works in essentially the same way but is produced by a different manufacturer. Think of it as a carefully crafted copy that meets the same safety and effectiveness standards as the original drug.

This medication is what doctors call a "VEGF inhibitor," which means it blocks a protein called vascular endothelial growth factor. This protein normally helps your body create new blood vessels, but cancer cells hijack this process to feed their growth. By blocking this protein, bevacizumab-maly essentially starves tumors of the blood supply they need to grow and spread.

The medication is given through an IV infusion, which means it flows directly into your bloodstream through a small tube placed in your vein. This allows the medicine to reach cancer cells throughout your body quickly and effectively.

What is Bevacizumab-maly Used For?

Bevacizumab-maly treats several types of advanced cancers, particularly those that have spread or returned after other treatments. Your oncologist will determine if this medication is right for your specific situation based on your cancer type, stage, and overall health.

The most common cancers treated with this medication include colorectal cancer that has spread to other parts of your body. It's also used for certain types of lung cancer, specifically non-small cell lung cancer, when combined with chemotherapy drugs.

Additionally, doctors prescribe bevacizumab-maly for some kidney cancers, certain brain tumors called glioblastomas, and specific types of cervical cancer. In some cases, it may be used for ovarian cancer that has returned after previous treatment.

Your healthcare team will carefully evaluate whether this treatment fits your individual cancer profile. The decision involves considering factors like your cancer's genetic makeup, how it has responded to previous treatments, and your overall health status.

How Does Bevacizumab-maly Work?

Bevacizumab-maly works by targeting the blood supply that feeds cancer tumors, essentially cutting off their lifeline. This approach is different from traditional chemotherapy, which directly attacks cancer cells.

Cancer cells are clever at creating their own blood vessel networks through a process called angiogenesis. They send out chemical signals that tell your body to grow new blood vessels toward the tumor. These new vessels bring oxygen and nutrients that help the cancer grow and spread to other parts of your body.

This medication acts like a targeted blocker, attaching itself to the VEGF protein that cancer cells use to signal for new blood vessels. When bevacizumab-maly binds to this protein, it prevents the signal from getting through, stopping new blood vessel formation.

Without a steady supply of nutrients and oxygen, tumors often shrink or stop growing. This can also make other cancer treatments more effective because the tumor becomes more vulnerable when it's struggling to maintain its blood supply.

How Should I Take Bevacizumab-maly?

Bevacizumab-maly is always given as an IV infusion in a medical facility, never as a pill you take at home. Your healthcare team will handle all the preparation and administration, so you don't need to worry about dosing yourself.

The infusion typically takes about 30 to 90 minutes, depending on your specific dose and how well you tolerate the treatment. Your first infusion may take longer as your medical team monitors you carefully for any reactions.

Before each treatment, you'll likely have blood tests to check your kidney function, blood pressure, and overall health. Your doctor may also recommend eating a light meal before your infusion to help prevent nausea, though there aren't specific dietary restrictions.

Plan to spend several hours at the treatment center for each session. Many patients find it helpful to bring a book, tablet, or other quiet activities to pass the time during the infusion.

How Long Should I Take Bevacizumab-maly For?

The length of your treatment depends on how your cancer responds and how well you tolerate the medication. Most patients receive treatments every 2 to 3 weeks, but your specific schedule will be tailored to your needs.

Some people may receive bevacizumab-maly for several months, while others might continue treatment for a year or more. Your oncologist will regularly assess your progress through imaging scans and blood tests to determine if the treatment is working effectively.

Treatment typically continues as long as your cancer is responding well and you're not experiencing severe side effects. Your doctor will discuss stopping criteria with you, which might include cancer progression, unacceptable side effects, or achievement of treatment goals.

It's important to maintain open communication with your healthcare team throughout treatment. They'll help you understand what to expect and when treatment decisions might need to be reconsidered.

What Are the Side Effects of Bevacizumab-maly?

Like all powerful medications, bevacizumab-maly can cause side effects, though not everyone experiences them. Most side effects are manageable with proper monitoring and supportive care from your medical team.

Here are the more common side effects you might experience during treatment:

• High blood pressure, which your doctor will monitor closely
• Fatigue or feeling more tired than usual
• Headaches that may come and go
• Nausea or loss of appetite
• Diarrhea or changes in bowel movements
• Protein in your urine, detected through routine testing
• Nosebleeds or minor bleeding
• Changes in your voice or hoarseness

These common side effects are usually mild to moderate and often improve as your body adjusts to the treatment. Your healthcare team has effective strategies to help manage these symptoms.

There are also some serious but less common side effects that require immediate medical attention. While these are rare, it's important to be aware of them:

• Severe bleeding, especially in your digestive system
• Blood clots in your legs or lungs
• Severe high blood pressure
• Kidney problems
• Slow wound healing or wound reopening
• Holes in your stomach or intestines (perforations)
• Heart problems
• Stroke or other serious bleeding in your brain

Your medical team will monitor you carefully for these serious side effects through regular check-ups and tests. Most patients tolerate treatment well, but knowing what to watch for helps ensure prompt treatment if needed.

Who Should Not Take Bevacizumab-maly?

Bevacizumab-maly isn't suitable for everyone, and your doctor will carefully evaluate your medical history before recommending this treatment. Certain health conditions or circumstances may make this medication too risky for you.

You should not receive bevacizumab-maly if you have recently had major surgery or are planning surgery soon. The medication can interfere with wound healing, so doctors typically wait at least 4 weeks after surgery before starting treatment.

People with certain bleeding disorders or those taking blood-thinning medications may not be good candidates for this treatment. Since bevacizumab-maly can increase bleeding risk, your doctor will carefully weigh the benefits against potential dangers.

If you have uncontrolled high blood pressure, severe kidney disease, or recent heart problems, your doctor may recommend alternative treatments. Additionally, if you're pregnant or breastfeeding, this medication is not recommended as it could harm your baby.

Your oncologist will review your complete medical history, current medications, and recent test results to determine if bevacizumab-maly is the right choice for your situation.

Bevacizumab-maly Brand Names

Bevacizumab-maly is the generic name for this medication, and it's available under the brand name Mvasi. This is the biosimilar version that works essentially the same way as the original bevacizumab medication.

The original bevacizumab is available under the brand name Avastin, and both medications are considered equally effective for treating cancer. Your doctor or insurance plan may prefer one version over the other, but both offer the same therapeutic benefits.

When discussing your treatment with healthcare providers, you might hear either the generic name (bevacizumab-maly) or the brand name (Mvasi). These terms refer to the same medication, so don't be confused if different team members use different names.

Bevacizumab-maly Alternatives

If bevacizumab-maly isn't suitable for you, several other treatment options might be available depending on your specific type of cancer. Your oncologist will help you explore these alternatives based on your individual situation.

Other targeted therapies work through different mechanisms to fight cancer. For example, medications called tyrosine kinase inhibitors can block cancer cell growth signals, while immunotherapy drugs help your immune system recognize and attack cancer cells.

Traditional chemotherapy remains an important treatment option for many cancers. These medications work by directly targeting rapidly dividing cells, including cancer cells, and can be very effective either alone or in combination with other treatments.

Your doctor might also consider radiation therapy, surgical options, or participation in clinical trials studying new treatments. The best alternative depends on your cancer type, stage, previous treatments, and overall health status.

Is Bevacizumab-maly Better Than Avastin?

Bevacizumab-maly (Mvasi) and Avastin are considered equally effective for treating cancer because they work through the same mechanism and produce similar results. The main difference is that bevacizumab-maly is a biosimilar version, which often costs less than the original medication.

Both medications have undergone rigorous testing to ensure they meet the same safety and effectiveness standards. Studies show that patients respond similarly to both versions, with comparable side effect profiles and treatment outcomes.

Your doctor's choice between these medications may depend on factors like your insurance coverage, the treatment center's preferred suppliers, or availability. From a medical standpoint, both are excellent options for appropriate cancer treatment.

The most important thing is that you receive the treatment that's best for your specific cancer type and situation, regardless of which brand name is used.